{"id":10623,"date":"2025-05-14T10:00:00","date_gmt":"2025-05-14T02:00:00","guid":{"rendered":"https:\/\/magazine-admin.circledna.com\/?p=10623"},"modified":"2025-05-05T15:26:51","modified_gmt":"2025-05-05T07:26:51","slug":"safe-medication-use-while-breastfeeding-dos-donts-and-genetic-metabolism","status":"publish","type":"post","link":"https:\/\/magazine.circledna.com\/safe-medication-use-while-breastfeeding-dos-donts-and-genetic-metabolism\/","title":{"rendered":"Safe Medication Use While Breastfeeding: Do\u2019s, Don\u2019ts, and Genetic Metabolism"},"content":{"rendered":"\n

Navigating breastfeeding medication safety<\/strong> can be challenging for new mothers. Understanding how drugs transfer to breast milk and the influence of CYP450 genetics<\/strong> on drug metabolism is crucial. This guide delves into the do’s and don’ts of medication use during lactation and how personalized insights from the CircleDNA pharmacogenomics<\/strong> test can aid in making informed decisions.<\/p>\n\n\n\n

Understanding Drug Transfer to Breast Milk<\/strong><\/h2>\n\n\n\n

Most medications taken by nursing mothers pass into breast milk to some extent. Factors influencing this transfer include the drug’s molecular weight, lipid solubility, protein binding, and half-life. Medications with low molecular weight and high lipid solubility are more likely to enter breast milk. <\/p>\n\n\n\n

The milk-to-plasma (M\/P) ratio<\/strong> is a key metric; an M\/P ratio less than 1 generally indicates minimal transfer to breast milk. Additionally, the Relative Infant Dose (RID)<\/strong>\u2014the percentage of the maternal dose received by the infant\u2014helps assess safety. An RID below 10% is typically considered acceptable.<\/p>\n\n\n\n

Do\u2019s and Don\u2019ts of Medication Use During Breastfeeding<\/strong><\/h2>\n\n\n\n

Do\u2019s:<\/strong><\/h3>\n\n\n\n